1
|
Ultra-low-dose CTKUB: the new standard of follow-up of ureteric calculi not visible on plain radiograph? Int Urol Nephrol 2022; 54:781-787. [PMID: 35129775 DOI: 10.1007/s11255-022-03134-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2021] [Accepted: 01/27/2022] [Indexed: 10/19/2022]
Abstract
PURPOSE With sensitivities over 95%, non-contrast computer tomography of kidney, ureter and bladder (CTKUB) is the investigation of choice in renal colic to diagnose or exclude ureteric calculi. CTKUB delivers an average effective radiation dose of 5.4 millisievert (mSv) and is used to follow-up calculi not visible on plain X-ray, whereas plain radiography has a radiation exposure of 0.7 mSv and is used to follow-up radio-opaque calculi. We assessed the effectiveness of using ultra-low-dose CTKUB (ULDCTKUB) for the follow-up of ureteric calculi not visible on plain radiograph of the kidneys, ureter and bladder (KUB), as an emerging option to reduce radiation exposure compared to standard dose CTKUB. METHODS Between 2013 and 2016 we retrospectively analysed 86 patients who underwent ULDCTKUB for CTKUB-confirmed ureteric calculi that were not visible on plain radiography. Patients were identified from our Radiology Management System with additional information from electronic patient records. RESULTS 98% of ULDCTKUBs were of diagnostic quality; two patients required further cross-sectional imaging. 67% of patients had passed their calculi after the initial diagnostic CTKUB. In the remaining 33% who had persistent calculi on ULDCTKUB, 20% required surgical intervention and 13% required no intervention. The mean ULDCTKUB effective radiation dose was six times lower than conventional CTKUB (0.8 vs 5.4 mSv). 67% of patients had a radiation dose equivalent to X-ray KUB (< 1 mSv). CONCLUSION ULDCTKUB is a reliable and safe follow-up investigation of ureteric calculi and has absorbed radiation doses similar to plain radiography and lower than annual background radiation. We advocate ULDCTKUB as the primary imaging modality in the follow-up of ureteric calculi not visible on plain radiograph.
Collapse
|
2
|
Moore CL, Bhargavan-Chatfield M, Shaw MM, Weisenthal K, Kalra MK. Radiation Dose Reduction in Kidney Stone CT: A Randomized, Facility-Based Intervention. J Am Coll Radiol 2021; 18:1394-1404. [PMID: 34115990 DOI: 10.1016/j.jacr.2021.05.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2021] [Revised: 05/05/2021] [Accepted: 05/11/2021] [Indexed: 10/21/2022]
Abstract
OBJECTIVE Kidney stones are common, tend to recur, and afflict a young population. Despite evidence and recommendations, adoption of reduced-radiation dose CT (RDCT) for kidney stone CT (KSCT) is slow. We sought to design and test an intervention to improve adoption of RDCT protocols for KSCT using a randomized facility-based intervention. METHODS Facilities contributing at least 40 KSCTs to the American College of Radiology dose index registry (DIR) during calendar year 2015 were randomized to intervention or control groups. The Dose Optimization for Stone Evaluation intervention included customized CME modules, personalized consultation, and protocol recommendations for RDCT. Dose length product (DLP) of all KSCTs was recorded at baseline (2015) and compared with 2017, 2018, and 2019. Change in mean DLP was compared between facilities that participated (intervened-on), facilities randomized to intervention that did not participate (intervened-off), and control facilities. Difference-in-difference between intervened-on and control facilities is reported before and after intervention. RESULTS Of 314 eligible facilities, 155 were randomized to intervention and 159 to control. There were 25 intervened-on facilities, 71 intervened-off facilities, and 96 control facilities. From 2015 to 2017, there was a drop of 110 mGy ∙ cm (a 16% reduction) in the mean DLP in the intervened-on group, which was significantly lower compared with the control group (P < .05). The proportion of RDCTs increased for each year in the intervened-on group relative to the other groups for all 3 years (P < .01). DISCUSSION The Dose Optimization for Stone Evaluation intervention resulted in a significant (P < .05) and persistent reduction in mean radiation doses for engaged facilities performing KSCTs.
Collapse
Affiliation(s)
- Christopher L Moore
- Chief, Ultrasound Section, Department of Emergency Medicine, Yale University School of Medicine, New Haven, Connecticut.
| | | | - Melissa M Shaw
- Yale University School of Medicine, New Haven, Connecticut
| | | | | |
Collapse
|
3
|
Danilovic A, Cavalanti A, Rocha BA, Traxer O, Torricelli FCM, Marchini GS, Mazzucchi E, Srougi M. Assessment of Residual Stone Fragments After Retrograde Intrarenal Surgery. J Endourol 2019; 32:1108-1113. [PMID: 30398369 DOI: 10.1089/end.2018.0529] [Citation(s) in RCA: 33] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
OBJECTIVES To define the most suitable approach to assess residual stone fragments after retrograde intrarenal surgery (RIRS). METHODS Ninety-two patients (115 renal units) submitted to RIRS for symptomatic kidney stones >5 mm and <20 mm or <15 mm in the lower Calyx diagnosed by noncontrast CT (NCCT) were prospectively studied. Residual fragments were assessed by endoscopic evaluation (END) at the end of the procedure and by NCCT, ultrasonography (US), and kidney, ureter, and bladder radiograph (KUB) on the 90th postoperative day (POD). NCCT was considered the gold standard for the evaluation of residual fragments after RIRS. RESULTS The 90th POD NCCT resulted in stone-free status in 74.8% (86/115), 0-2 mm in 8.7% (10/115), and >2 mm residual fragments in 16.5% (19/115) renal units. Stone-free status by END at the end of RIRS was coincident with NCCT in 93.0% of the cases (40/43). There were no cases of residual fragments >2 mm on NCCT if END resulted in stone-free status. In all cases where END resulted in residual fragments >2 mm, US proved to be correct according to NCCT. Neither US nor KUB was able to identify residual fragments between 0 and 2 mm. KUB had only 31.6% (6/19) sensitivity to detect residual fragments >2 mm and did not add sensitivity or specificity to US. CONCLUSIONS In the follow-up imaging after RIRS, we suggest that if END resulted in residual fragments <2 mm, a 90th POD NCCT should be performed. US may be used if END showed fragments >2 mm.
Collapse
Affiliation(s)
- Alexandre Danilovic
- 1 Department of Urology and Hospital das Clinicas, University of Sao Paulo Medical School , Sao Paulo, Brazil
| | - Andrea Cavalanti
- 2 Department of Radiology, Hospital das Clinicas, University of Sao Paulo Medical School , Sao Paulo, Brazil
| | - Bruno Aragão Rocha
- 2 Department of Radiology, Hospital das Clinicas, University of Sao Paulo Medical School , Sao Paulo, Brazil
| | - Olivier Traxer
- 3 Sorbonne Université , GRC n 20 Lithiase Renale, AP-HP, Hôpital Tenon, Paris, France
| | | | - Giovanni Scala Marchini
- 1 Department of Urology and Hospital das Clinicas, University of Sao Paulo Medical School , Sao Paulo, Brazil
| | - Eduardo Mazzucchi
- 1 Department of Urology and Hospital das Clinicas, University of Sao Paulo Medical School , Sao Paulo, Brazil
| | - Miguel Srougi
- 1 Department of Urology and Hospital das Clinicas, University of Sao Paulo Medical School , Sao Paulo, Brazil
| |
Collapse
|
4
|
Danilovic A, Rocha BA, Marchini GS, Traxer O, Batagello C, Vicentini FC, Torricelli FCM, Srougi M, Nahas WC, Mazzucchi E. Computed tomography window affects kidney stones measurements. Int Braz J Urol 2019; 45:948-955. [PMID: 31268643 PMCID: PMC6844354 DOI: 10.1590/s1677-5538.ibju.2018.0819] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2018] [Accepted: 03/19/2019] [Indexed: 11/21/2022] Open
Abstract
OBJECTIVES Measurements of stone features may vary according to the non-contrast computed tomography (NCCT) technique. Using magnified bone window is the most accurate method to measure urinary stones. Possible differences between stone measurements in different NCCT windows have not been evaluated in stones located in the kidney. The aim of this study is to compare measurements of kidney stone features between NCCT bone and soft tissue windows in patients submitted to retrograde intrarenal surgery (RIRS). MATERIALS AND METHODS Preoperative and 90th postoperative day NCCT were performed in 92 consecutive symptomatic adult patients (115 renal units) with kidney stones between 5 mm to 20 mm (< 15 mm in the lower calyx) treated by RIRS. NCCT were evaluated in the magnified bone window and soft tissue window in three axes in a different time by a single radiologist blinded for the measurements of the NCCT other method. RESULTS Stone largest size (7.92±3.81 vs. 9.13±4.08; mm), volume (435.5±472.7 vs. 683.1±665.0; mm3) and density (989.4±330.2 vs. 893.0±324.6; HU) differed between bone and soft-tissue windows, respectively (p<0.0001) 5.2% of the renal units (6/115) were reclassified from residual fragments > 2 mm on soft tissue window to 0-2 mm on bone window. CONCLUSION Kidney stone measurements vary according to NCCT window. Measurements in soft tissue window NCCT of stone diameter and volume are larger and stone density is lesser than in bone window. These differences may have impact on clinical decisions.
Collapse
Affiliation(s)
- Alexandre Danilovic
- Departamento de Urologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, SP, Brasil
| | - Bruno Aragão Rocha
- Departamento de Radiologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, SP, Brasil
| | - Giovanni Scala Marchini
- Departamento de Urologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, SP, Brasil
| | - Olivier Traxer
- Sorbonne Université, GRC n 20 Lithiase Renale, AP-HP, Hôpital Tenon, F-75020 Paris, France. University, Paris, France
| | - Carlos Batagello
- Departamento de Urologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, SP, Brasil
| | - Fabio Carvalho Vicentini
- Departamento de Urologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, SP, Brasil
| | | | - Miguel Srougi
- Departamento de Urologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, SP, Brasil
| | - William Carlos Nahas
- Departamento de Urologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, SP, Brasil
| | - Eduardo Mazzucchi
- Departamento de Urologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, SP, Brasil
| |
Collapse
|
5
|
Kataria B, Nilsson Althén J, Smedby Ö, Persson A, Sökjer H, Sandborg M. Image quality and pathology assessment in CT Urography: when is the low-dose series sufficient? BMC Med Imaging 2019; 19:64. [PMID: 31399078 PMCID: PMC6688276 DOI: 10.1186/s12880-019-0363-z] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2019] [Accepted: 07/29/2019] [Indexed: 12/28/2022] Open
Abstract
BACKGROUND Our aim was to compare CT images from native, nephrographic and excretory phases using image quality criteria as well as the detection of positive pathological findings in CT Urography, to explore if the radiation burden to the younger group of patients or patients with negative outcomes can be reduced. METHODS This is a retrospective study of 40 patients who underwent a CT Urography examination on a 192-slice dual source scanner. Image quality was assessed for four specific renal image criteria from the European guidelines, together with pathological assessment in three categories: renal, other abdominal, and incidental findings without clinical significance. Each phase was assessed individually by three radiologists with varying experience using a graded scale. Certainty scores were derived based on the graded assessments. Statistical analysis was performed using visual grading regression (VGR). The limit for significance was set at p = 0.05. RESULTS For visual reproduction of the renal parenchyma and renal arteries, the image quality was judged better for the nephrogram phase (p < 0.001), whereas renal pelvis/calyces and proximal ureters were better reproduced in the excretory phase compared to the native phase (p < 0.001). Similarly, significantly higher certainty scores were obtained in the nephrogram phase for renal parenchyma and renal arteries, but in the excretory phase for renal pelvis/calyxes and proximal ureters. Assessment of pathology in the three categories showed no statistically significant differences between the three phases. Certainty scores for assessment of pathology, however, showed a significantly higher certainty for renal pathology when comparing the native phase to nephrogram and excretory phase and a significantly higher score for nephrographic phase but only for incidental findings. CONCLUSION Visualisation of renal anatomy was as expected with each post-contrast phase showing favourable scores compared to the native phase. No statistically significant differences in the assessment of pathology were found between the three phases. The low-dose CT (LDCT) seems to be sufficient in differentiating between normal and pathological examinations. To reduce the radiation burden in certain patient groups, the LDCT could be considered a suitable alternative as a first line imaging method. However, radiologists should be aware of its limitations.
Collapse
Affiliation(s)
- Bharti Kataria
- Department of Radiology, Linköping University, Linköping, Sweden. .,Department of Medical & Health Sciences, Linköping University, Linköping, Sweden. .,Center for Medical Image Science & Visualization (CMIV), Linköping University, Linköping, Sweden.
| | - Jonas Nilsson Althén
- Department of Medical & Health Sciences, Linköping University, Linköping, Sweden.,Department of Medical Physics, Linköping University, Linköping, Sweden
| | - Örjan Smedby
- Department of Biomedical Engineering and Health Systems (MTH), KTH Royal Institute of Technology, Stockholm, Sweden
| | - Anders Persson
- Department of Radiology, Linköping University, Linköping, Sweden.,Department of Medical & Health Sciences, Linköping University, Linköping, Sweden.,Center for Medical Image Science & Visualization (CMIV), Linköping University, Linköping, Sweden
| | - Hannibal Sökjer
- Department of Medical & Health Sciences, Linköping University, Linköping, Sweden
| | - Michael Sandborg
- Department of Medical & Health Sciences, Linköping University, Linköping, Sweden.,Center for Medical Image Science & Visualization (CMIV), Linköping University, Linköping, Sweden.,Department of Medical Physics, Linköping University, Linköping, Sweden
| |
Collapse
|
6
|
Stone-free Outcomes of Flexible Ureteroscopy for Renal Calculi Utilizing Computed Tomography Imaging. Urology 2019; 124:52-56. [DOI: 10.1016/j.urology.2018.09.005] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2018] [Revised: 09/04/2018] [Accepted: 09/06/2018] [Indexed: 12/15/2022]
|
7
|
Ahn JH, Kim SH, Kim SJ, Nam IC, Lee SJ, Pak SY. Diagnostic performance of advanced modeled iterative reconstruction applied images for detecting urinary stones on submillisievert low-dose computed tomography. Acta Radiol 2018; 59:1002-1009. [PMID: 29067815 DOI: 10.1177/0284185117738548] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
Background Repeated computed tomography (CT) scans may be an issue in young adults with urinary stones. Therefore, it is important to know how far the dose can be reduced while maintaining the diagnostic performance. Purpose To generate a hypothesis that it is feasible to decrease the radiation dose to a sub-millisievert (mSv) level with the addition of advanced modeled iterative reconstruction (ADMIRE) while maintaining the sensitivity to standard-dose CT (SDCT) for the detection of urinary stones. Material and Methods Ninety-two consecutive patients with urinary stones underwent non-enhanced CT that consisted of standard (120 kVp, 200 mAs) and lose-dose (LDCT) (80 kVp, 60 mAs). The LDCT images were reconstructed separately with five different strengths of ADMIRE (hereafter, S1-S5) and filtered back projection (FBP). Two blinded radiologists independently recorded a number of urinary stones in the six LDCT datasets and SDCT. The sensitivity of each set for detecting urinary stones was compared using the McNemar test. Results A total of 240 urinary stones were analyzed. The sensitivities of the six LDCT datasets showed no difference (FBP, S1-S5, for reader 1: 78%, 79%, 79%, 80%, 80%, and 80%; for reader 2: 64%, 63%, 64%, 64%, 65%, and 66%, P > 0.05, respectively), which were lower than those of SDCT for both readers (reader 1: 88%; reader 2: 81%, P < 0.0001, respectively). Conclusion Despite the addition of ADMIRE, it may not be feasible to decrease the radiation dose to a sub-mSv level while maintaining the sensitivity to SDCT for the detection of urinary stones.
Collapse
Affiliation(s)
- Ju Hee Ahn
- Department of Radiology, Inje University College of Medicine, Haeundae Paik Hospital, Busan, Republic of Korea
| | - Seung Ho Kim
- Department of Radiology, Inje University College of Medicine, Haeundae Paik Hospital, Busan, Republic of Korea
| | - Seung Jin Kim
- Department of Radiology, Inje University College of Medicine, Haeundae Paik Hospital, Busan, Republic of Korea
| | - In Chul Nam
- Department of Radiology, Inje University College of Medicine, Haeundae Paik Hospital, Busan, Republic of Korea
| | - Sung Jae Lee
- Department of Radiology, Inje University College of Medicine, Haeundae Paik Hospital, Busan, Republic of Korea
| | - Seong Yong Pak
- Department of CT research collaborations, SIEMENS Healthcare Ltd., Poongsan Building, Seoul, Republic of Korea
| |
Collapse
|
8
|
Weisenthal K, Karthik P, Shaw M, Sengupta D, Bhargavan-Chatfield M, Burleson J, Mustafa A, Kalra M, Moore C. Evaluation of Kidney Stones with Reduced-Radiation Dose CT: Progress from 2011-2012 to 2015-2016-Not There Yet. Radiology 2017; 286:581-589. [PMID: 28858562 DOI: 10.1148/radiol.2017170285] [Citation(s) in RCA: 40] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
Purpose To determine if the use of reduced-dose computed tomography (CT) for evaluation of kidney stones increased in 2015-2016 compared with that in 2011-2012, to determine variability in radiation exposure according to facility for this indication, and to establish a current average radiation dose for CT evaluation for kidney stones by querying a national dose registry. Materials and Methods This cross-sectional study was exempt from institutional review board approval. Data were obtained from the American College of Radiology dose registry for CT examinations submitted from July 2015 to June 2016. Study descriptors consistent with single-phase unenhanced CT for evaluation of kidney stones and associated RadLex® Playbook identifiers (RPIDs) were retrospectively identified. Facilities actively submitting data on kidney stone-specific CT examinations were included. Dose metrics including volumetric CT dose index, dose-length product, and size-specific dose estimate, when available, were reported, and a random effects model was run to account for clustering of CT examinations at facilities. A z-ratio was calculated to test for a significant difference between the proportion of reduced-radiation dose CT examinations (defined as those with a dose-length product of 200 mGy · cm or less) performed in 2015-2016 and the proportion performed in 2011-2012. Results Three hundred four study descriptors for kidney stone CT corresponding to data from 328 facilities that submitted 105 334 kidney stone CT examinations were identified. Reduced-dose CT examinations accounted for 8040 of 105 334 (7.6%) CT examinations, a 5.6% increase from the 1010 of 49 903 (2%) examinations in 2011-2012 (P < .001). Mean overall dose-length product was 689 mGy · cm (95% confidence interval: 667, 712), decreased from the mean of 746 mGy · cm observed in 2011-2012. Median facility dose-length product varied up to sevenfold, from less than 200 mGy · cm to greater than 1600 mGy · cm. Conclusion Use of reduced-radiation dose CT for evaluation of kidney stones has increased since 2011-2012, but remains low; variability of radiation dose according to facility continues to be wide. National mean CT radiation exposure for evaluation of renal colic during 2015-2016 decreased relative to 2011-2012 values, but remained well above what is reasonably achievable. © RSNA, 2017.
Collapse
Affiliation(s)
- Karrin Weisenthal
- From the Departments of Emergency Medicine, (K.W., M.S., C.M.) and Radiology and Biomedical Imaging (A.M.), Yale School of Medicine, 464 Congress Ave, Suite 273, New Haven, CT 06510; Department of Quality and Safety, American College of Radiology, Reston, Va (P.K., D.S., M.B.C., J.B.); and Department of Radiology, Massachusetts General Hospital, Boston, Mass (M.K.)
| | - Priyadarshini Karthik
- From the Departments of Emergency Medicine, (K.W., M.S., C.M.) and Radiology and Biomedical Imaging (A.M.), Yale School of Medicine, 464 Congress Ave, Suite 273, New Haven, CT 06510; Department of Quality and Safety, American College of Radiology, Reston, Va (P.K., D.S., M.B.C., J.B.); and Department of Radiology, Massachusetts General Hospital, Boston, Mass (M.K.)
| | - Melissa Shaw
- From the Departments of Emergency Medicine, (K.W., M.S., C.M.) and Radiology and Biomedical Imaging (A.M.), Yale School of Medicine, 464 Congress Ave, Suite 273, New Haven, CT 06510; Department of Quality and Safety, American College of Radiology, Reston, Va (P.K., D.S., M.B.C., J.B.); and Department of Radiology, Massachusetts General Hospital, Boston, Mass (M.K.)
| | - Debapriya Sengupta
- From the Departments of Emergency Medicine, (K.W., M.S., C.M.) and Radiology and Biomedical Imaging (A.M.), Yale School of Medicine, 464 Congress Ave, Suite 273, New Haven, CT 06510; Department of Quality and Safety, American College of Radiology, Reston, Va (P.K., D.S., M.B.C., J.B.); and Department of Radiology, Massachusetts General Hospital, Boston, Mass (M.K.)
| | - Mythreyi Bhargavan-Chatfield
- From the Departments of Emergency Medicine, (K.W., M.S., C.M.) and Radiology and Biomedical Imaging (A.M.), Yale School of Medicine, 464 Congress Ave, Suite 273, New Haven, CT 06510; Department of Quality and Safety, American College of Radiology, Reston, Va (P.K., D.S., M.B.C., J.B.); and Department of Radiology, Massachusetts General Hospital, Boston, Mass (M.K.)
| | - Judy Burleson
- From the Departments of Emergency Medicine, (K.W., M.S., C.M.) and Radiology and Biomedical Imaging (A.M.), Yale School of Medicine, 464 Congress Ave, Suite 273, New Haven, CT 06510; Department of Quality and Safety, American College of Radiology, Reston, Va (P.K., D.S., M.B.C., J.B.); and Department of Radiology, Massachusetts General Hospital, Boston, Mass (M.K.)
| | - Adel Mustafa
- From the Departments of Emergency Medicine, (K.W., M.S., C.M.) and Radiology and Biomedical Imaging (A.M.), Yale School of Medicine, 464 Congress Ave, Suite 273, New Haven, CT 06510; Department of Quality and Safety, American College of Radiology, Reston, Va (P.K., D.S., M.B.C., J.B.); and Department of Radiology, Massachusetts General Hospital, Boston, Mass (M.K.)
| | - Mannudeep Kalra
- From the Departments of Emergency Medicine, (K.W., M.S., C.M.) and Radiology and Biomedical Imaging (A.M.), Yale School of Medicine, 464 Congress Ave, Suite 273, New Haven, CT 06510; Department of Quality and Safety, American College of Radiology, Reston, Va (P.K., D.S., M.B.C., J.B.); and Department of Radiology, Massachusetts General Hospital, Boston, Mass (M.K.)
| | - Christopher Moore
- From the Departments of Emergency Medicine, (K.W., M.S., C.M.) and Radiology and Biomedical Imaging (A.M.), Yale School of Medicine, 464 Congress Ave, Suite 273, New Haven, CT 06510; Department of Quality and Safety, American College of Radiology, Reston, Va (P.K., D.S., M.B.C., J.B.); and Department of Radiology, Massachusetts General Hospital, Boston, Mass (M.K.)
| |
Collapse
|
9
|
Moore CL, Daniels B, Singh D, Luty S, Gunabushanam G, Ghita M, Molinaro A, Gross CP. Ureteral Stones: Implementation of a Reduced-Dose CT Protocol in Patients in the Emergency Department with Moderate to High Likelihood of Calculi on the Basis of STONE Score. Radiology 2016; 280:743-51. [PMID: 26943230 DOI: 10.1148/radiol.2016151691] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Purpose To determine if a reduced-dose computed tomography (CT) protocol could effectively help to identify patients in the emergency department (ED) with moderate to high likelihood of calculi who would require urologic intervention within 90 days. Materials and Methods The study was approved by the institutional review board and written informed consent with HIPAA authorization was obtained. This was a prospective, single-center study of patients in the ED with moderate to high likelihood of ureteral stone undergoing CT imaging. Objective likelihood of ureteral stone was determined by using the previously derived and validated STONE clinical prediction rule, which includes five elements: sex, timing, origin, nausea, and erythrocytes. All patients with high STONE score (STONE score, 10-13) underwent reduced-dose CT, while those with moderate likelihood of ureteral stone (moderate STONE score, 6-9) underwent reduced-dose CT or standard CT based on clinician discretion. Patients were followed to 90 days after initial imaging for clinical course and for the primary outcome of any intervention. Statistics are primarily descriptive and are reported as percentages, sensitivities, and specificities with 95% confidence intervals. Results There were 264 participants enrolled and 165 reduced-dose CTs performed; of these participants, 108 underwent reduced-dose CT alone with complete follow-up. Overall, 46 of 264 (17.4%) of patients underwent urologic intervention, and 25 of 108 (23.1%) patients who underwent reduced-dose CT underwent a urologic intervention; all were correctly diagnosed on the clinical report of the reduced-dose CT (sensitivity, 100%; 95% confidence interval: 86.7%, 100%). The average dose-length product for all standard-dose CTs was 857 mGy · cm ± 395 compared with 101 mGy · cm ± 39 for all reduced-dose CTs (average dose reduction, 88.2%). There were five interventions for nonurologic causes, three of which were urgent and none of which were missed when reduced-dose CT was performed. Conclusion A CT protocol with over 85% dose reduction can be used in patients with moderate to high likelihood of ureteral stone to safely and effectively identify patients in the ED who will require urologic intervention. (©) RSNA, 2016 Online supplemental material is available for this article.
Collapse
Affiliation(s)
- Christopher L Moore
- From the Department of Emergency Medicine (C.L.M., B.D.), Department of Urology (D.S.), Yale Center for Clinical Investigation (S.L.), Department of Diagnostic Radiology (G.G.), and Department of Internal Medicine (C.P.G.), Yale University School of Medicine, 464 Congress Ave, Suite 260, New Haven, CT 06519; Department of Radiology, Virginia Commonwealth University, Richmond, Va (M.G.); and Department of Epidemiology and Biostatistics, University of California, San Francisco Medical Center, San Francisco, Calif (A.M.)
| | - Brock Daniels
- From the Department of Emergency Medicine (C.L.M., B.D.), Department of Urology (D.S.), Yale Center for Clinical Investigation (S.L.), Department of Diagnostic Radiology (G.G.), and Department of Internal Medicine (C.P.G.), Yale University School of Medicine, 464 Congress Ave, Suite 260, New Haven, CT 06519; Department of Radiology, Virginia Commonwealth University, Richmond, Va (M.G.); and Department of Epidemiology and Biostatistics, University of California, San Francisco Medical Center, San Francisco, Calif (A.M.)
| | - Dinesh Singh
- From the Department of Emergency Medicine (C.L.M., B.D.), Department of Urology (D.S.), Yale Center for Clinical Investigation (S.L.), Department of Diagnostic Radiology (G.G.), and Department of Internal Medicine (C.P.G.), Yale University School of Medicine, 464 Congress Ave, Suite 260, New Haven, CT 06519; Department of Radiology, Virginia Commonwealth University, Richmond, Va (M.G.); and Department of Epidemiology and Biostatistics, University of California, San Francisco Medical Center, San Francisco, Calif (A.M.)
| | - Seth Luty
- From the Department of Emergency Medicine (C.L.M., B.D.), Department of Urology (D.S.), Yale Center for Clinical Investigation (S.L.), Department of Diagnostic Radiology (G.G.), and Department of Internal Medicine (C.P.G.), Yale University School of Medicine, 464 Congress Ave, Suite 260, New Haven, CT 06519; Department of Radiology, Virginia Commonwealth University, Richmond, Va (M.G.); and Department of Epidemiology and Biostatistics, University of California, San Francisco Medical Center, San Francisco, Calif (A.M.)
| | - Gowthaman Gunabushanam
- From the Department of Emergency Medicine (C.L.M., B.D.), Department of Urology (D.S.), Yale Center for Clinical Investigation (S.L.), Department of Diagnostic Radiology (G.G.), and Department of Internal Medicine (C.P.G.), Yale University School of Medicine, 464 Congress Ave, Suite 260, New Haven, CT 06519; Department of Radiology, Virginia Commonwealth University, Richmond, Va (M.G.); and Department of Epidemiology and Biostatistics, University of California, San Francisco Medical Center, San Francisco, Calif (A.M.)
| | - Monica Ghita
- From the Department of Emergency Medicine (C.L.M., B.D.), Department of Urology (D.S.), Yale Center for Clinical Investigation (S.L.), Department of Diagnostic Radiology (G.G.), and Department of Internal Medicine (C.P.G.), Yale University School of Medicine, 464 Congress Ave, Suite 260, New Haven, CT 06519; Department of Radiology, Virginia Commonwealth University, Richmond, Va (M.G.); and Department of Epidemiology and Biostatistics, University of California, San Francisco Medical Center, San Francisco, Calif (A.M.)
| | - Annette Molinaro
- From the Department of Emergency Medicine (C.L.M., B.D.), Department of Urology (D.S.), Yale Center for Clinical Investigation (S.L.), Department of Diagnostic Radiology (G.G.), and Department of Internal Medicine (C.P.G.), Yale University School of Medicine, 464 Congress Ave, Suite 260, New Haven, CT 06519; Department of Radiology, Virginia Commonwealth University, Richmond, Va (M.G.); and Department of Epidemiology and Biostatistics, University of California, San Francisco Medical Center, San Francisco, Calif (A.M.)
| | - Cary P Gross
- From the Department of Emergency Medicine (C.L.M., B.D.), Department of Urology (D.S.), Yale Center for Clinical Investigation (S.L.), Department of Diagnostic Radiology (G.G.), and Department of Internal Medicine (C.P.G.), Yale University School of Medicine, 464 Congress Ave, Suite 260, New Haven, CT 06519; Department of Radiology, Virginia Commonwealth University, Richmond, Va (M.G.); and Department of Epidemiology and Biostatistics, University of California, San Francisco Medical Center, San Francisco, Calif (A.M.)
| |
Collapse
|